Cultured rat embryonic cortical neurons undergo apoptosis when treated with the topoisomerase-I inhibitor camptothecin. Pharmacological or molecular caspase inhibition prevents apoptosis, but the neurons still die in a delayed nonapoptotic manner. Here we examine the mechanisms leading to such caspase-independent death, focusing on events related to mitochondrial malfunction, which accompanies this delayed death. Given that mitochondria are the major source of ATP in primary neurons, we examined the cellular energy state. Mitochondrially generated ATP was specifically reduced in neurons treated with camptothecin and Boc-aspartyl-fluoromethylketone. Augmentation of cellular ATP by manipulation of the glucose content in the cultures led to an increase in survival specifically in delayed caspase-independent but not early caspase-dependent death. As another possible consequence of mitochondrial malfunction, we found an induction of reactive oxygen species in delayed death. The free radical scavenger Tempol, but not other classes of antioxidants, reduced oxidative stress and promoted survival. Other potential events known to be a direct or indirect consequence of mitochondrial dysfunction, such as the induction of autophagy, release of apoptosis-inducing factor, or opening of the mitochondrial permeability transition pore, were not found to play a significant role in caspase-independent neuronal death. Combining the strategies of increasing intracellular ATP and reducing free radicals led to an additive increase in neuronal survival. We conclude that energy failure and free radical generation contribute to caspase-independent neuronal death. Both could represent potential targets for therapeutic interventions complementary to caspase inhibition.
Introduction
Inhibition of caspases has been suggested as a therapeutic strategy in neurodegenerative and acute neurological disorders (Schulz et al., 1999; . Indeed, in some animal models of disease, pharmacological caspase inhibitors have been shown to offer some protection against neuronal death and, in some cases, to ameliorate clinical manifestations (Cutillas et al., 1999; Li et al., 2000; Cao et al., 2002; Knoblach et al., 2002) . However, there is increasing evidence, primarily from neuronal cell culture models, that caspase inhibition offers only transient protection, and that caspase-independent death eventually occurs (Stefanis et al., 1999; Keramaris et al., 2000; Selznik et al., 2000) . Elucidating the mechanisms of caspase-independent death cannot only provide fundamental insights into biologically relevant cell death pathways but also identify targets for therapeutic intervention that are complementary to caspase inhibition.
In this study, we examined the mechanism of caspaseindependent death of rat embryonic cortical neurons treated with camptothecin (cam) and the general caspase inhibitor Bocaspartyl-fluoromethylketone (BAF). The topoisomerase-I inhibitor camptothecin induces rapid apoptotic death in these cultures. Studies of the mechanism of camptothecin-induced neuronal apoptosis suggest a model in which DNA damage leads to parallel activation of cell cycle components and p53. This leads to Bax-dependent release of cytochrome c from the mitochondria and consequent activation of caspases (Xiang et al., 1998; Stefanis et al., 1999; Morris et al., 2001) . We have shown previously that the general pharmacological caspase inhibitor BAF inhibits apoptotic death in this model; however, neurons subsequently undergo a delayed caspase-independent cell death lacking the nuclear features of apoptosis (Stefanis et al., 1999) . BAF does not prevent loss of cytochrome c and only delays loss of mitochondrial transmembrane potential (MTP) in this model. However, Bax-deficient neurons, which do not undergo mitochondrial alterations, almost completely resist camptothecin-induced death (Xiang et al., 1998; Morris et al., 2001) . Thus, the mitochondria lie at a crucial checkpoint in the course of events leading to cell death. If mitochondrial function is disrupted, even complete blockade of the apoptotic pathway downstream of this disruption does not lead to sustained survival. Mitochondrial dysfunction can lead to a disruption of electron transport and energy metabolism, as well as an impaired regulation of the cellular redox potential (Green and Reed, 1998) . Mitochondrial alterations have also been linked to autophagy (Lemasters et al., 1998; Xue et al., 1999 Xue et al., , 2001 Elmore et al., 2001 ). In addition, mitochondria have been shown to release, in addition to cytochrome c, other death-inducing proteins such as the apoptosis-inducing factor (AIF), which may act in a caspase-independent manner (Daugas et al., 2000) .
In the current study, we examined the role of several potential events known to be a direct or indirect consequence of mitochondrial dysfunction in caspase-independent neuronal death. We focus in particular on the generation of reactive oxygen species (ROS), induction of autophagy, release of AIF, and mitochondrial energy production.
Materials and Methods

Cell culture
Primary cortical neurons from embryonic day (E) 18 rats were prepared as described previously (Friedman, 1993; Stefanis et al., 1999; Rideout and Stefanis, 2002) . Briefly, after dissection of the cortical mantle, the tissue was dissociated by mechanical trituration. The cells were then resuspended in neurobasal medium supplemented with B-27, 0.5 mM L-glutamine, and 1% penicillin-streptomycin (Invitrogen, Grand Island, NY) and plated in poly-D-lysine-coated tissue cultures dishes. Using such procedures, free of the use of serum, Ͼ98% of the cultured cells represent neurons (Friedman et al., 1993; Rideout and Stefanis, 2002) . For certain experiments, cells were resuspended instead in other specific media, either neurobasal medium supplemented with antioxidant-free B-27, or glucose-free RPMI supplemented with regular B-27 (Invitrogen) and 5 mM pyruvate. Cultures were maintained at 37°C in a humidified atmosphere containing 5% CO 2 .
Application of reagents
On the first or second day after plating, cortical neurons were treated with 10 M cam alone or in combination with 100 M Boc-aspartyl (OMe)-fluoromethylketone (Enzyme Systems Products, Livermore, CA) as described previously (Stefanis et al., 1999) . In some experiments, the neurons were treated concomitantly with one of the following substances: vitamin E (0.1-1 mg/ml), Mn (III)tetrakis(4-benzoic acid) porphyrin chloride (MnTBAP; 100 M; Calbiochem, San Diego, CA), Mn(III) tetrakis (1-methyl-4-pyridyl) porphyrin pentachloride (MnTMPyP; 100 M; Calbiochem), Trolox (100 -200 g/ml; Calbiochem), N-acetylcysteine (NAC) (0.1-1 mM), L-␥-glutamyl-L-cysteinyl ethyl glycinate (GSH-MEE; 500 M, Calbiochem), 4,5, dihydroxybenzenedisulfonic acid (Tiron; 5 mM), cyclosporine A (1 M), bonkrekic acid (5-50 M), 3-methyladenine (10 mM), bafilomycin (2.5 nM), 4-hydroxytetramethyl-piperidine-1-oxyl (Tempol; 5 mM; Calbiochem), or D-glucose (4 mg/ml). If not otherwise specified, reagents were purchased from Sigma (St. Louis, MO).
Assessment of survival
Twelve or twenty hours after application of the above reagents, cortical neurons were lysed, and the number of intact nuclei was counted in a hemacytometer as described previously (Rukenstein et al., 1991; Stefanis et al., 1999) . This method has been shown to be reproducible and accurate and to correlate well with other methods of assessing cell survivaldeath (Stefanis et al., 1997 (Stefanis et al., , 1999 . Positive results were verified by counting the number of viable (calcein AM positive; see below) neurons in a defined number of fields in each well. All counts were conducted in a blinded manner. Cell counts were performed in triplicate and are reported as means Ϯ SEM. The data are expressed as the percentage of the number of neurons in the control cultures (i.e., cultures that were treated with no additives) at each time point. At least 100 neurons per well were counted for each one in control conditions. All data shown are representative of at least three replicate experiments.
Application of fluorescent dyes
Lysosomal function. E18 cortical neuron cultures were treated with various agents as described above and then labeled with LysoTracker Red, a fluorescent dye that accumulates specifically in acidic organelles. Thus, LysoTracker Red primarily labels functional lysosomes, which are the intracellular organelles that contain acidic enzymes and have a low pH . The cultures were incubated at 37°C for 20 min with 50 nM Lysotracker Red and then, after one rinse and replacement of the medium, they were visualized by fluorescence microscopy, and representative photomicrographs were obtained.
ROS generation. Two separate dyes that react with reactive oxygen species and thus lead to the emission of a fluorescent signal were used. In these experiments, to assess only cells that remained alive but yet had accumulated ROS, we prelabeled the cultures with the viability indicator calcein AM (4 M). To emit a fluorescent signal at the fluorescein range, this dye needs to be hydrolyzed by intracellular esterases and prevented from diffusing from the cell by an intact outer cell membrane. The cultures were incubated in the presence of calcein AM for 30 min at 37°C and then rinsed and incubated for another 30 min in the absence of calcein AM to allow its diffusion from neurons with a damaged cell membrane. Subsequently, the cultures were exposed to medium containing dihydroethidium (DHE; 1 M) for 30 min at 37°C. When DHE reacts with intracellular ROS, it fluoresces in the rhodamine spectrum within cell nuclei (Krohn et al., 1998) . After DHE labeling, the cultures were rinsed once, replenished with fresh medium, and visualized under a fluorescence microscope. The percentage of green-fluorescing (i.e., viable) cells that showed red nuclear fluorescence (i.e., ROS generation) was assessed in each setting. Counts were performed in triplicate and are reported as means Ϯ SEM. As a complementary approach, we also used the dye dichlorodihydrofluorescein diacetate (DCF; 75 M), which also fluoresces within cells after exposure to ROS (Hsu et al., 2000) .
Mitochondrial transmembrane potential. Cortical neuron cultures after various treatments, as described above, were incubated with medium containing tetramethylrhodamine methyl ester (TMRM; 50 nM) and calcein AM (4 M) for 20 min at 37°C. After a rinse, and an additional 30 min incubation of the cultures in fresh medium, we assessed the percentage of live (calcein-positive) neurons that still maintained TMRM fluorescence. Counts were conducted in a blinded manner. Cell counts were performed in triplicate and are reported as means Ϯ SEM. TMRM fluorescence has been validated across other methods as an accurate way to assess MTP (Metivier et al., 1998; ). All fluorescent dyes were obtained from Molecular Probes (Eugene, OR).
Immunofluorescence
Cortical neuron cultures on glass slides were first incubated for 30 min at 37°C with the mitochondrial dye Mitotracker Green (500 nM). This dye labels mitochondria regardless of transmembrane potential and thus serves as a mitochondrial marker. The cultures were then rinsed three times with PBS and fixed with 3.7% paraformaldehyde and 0.19% picric acid in PBS for 20 min at 4°C. After rinsing with PBS, the cells were incubated at room temperature (RT) for 30 min with blocking solution [10% normal goat serum (NGS) in PBS with 0.4% Triton X-100]. They were then incubated for 1 hr at RT with a mouse monoclonal antibody against AIF (Santa Cruz Biotechnology, Santa Cruz, CA) diluted 1:100 in 1% NGS in PBS with 0.4% Triton X-100. After three washes with PBS, the secondary antibody (Jackson ImmunoResearch, West Grove, PA; 1:100 of goat Cy3-conjugated anti-mouse, in 1% NGS in PBS with 0.4% Triton X-100) was applied for 30 min at RT. After additional washes, the nuclear dye TOTO-3 iodide (Molecular Probes; 1:1400) was applied to the cells and then rinsed with PBS. Coverslips were applied, and the cells were then visualized under a confocal microscope.
As an alternative for AIF immunostaining, we used similar procedures as described above to immunostain cultures with a combination of a rabbit anti-AIF antiserum (1:500; generously provided by Drs. Kroemer and Susin, Centre National de la Recherche Scientifique, Institut Gustav Roussy, Villejuif, France) and a monoclonal antibody directed against subunit IV of cytochrome oxidase (COX; 1:2500; Molecular Probes). COX forms part of the mitochondrial matrix and is thus not released during events leading to the release of other mitochondrial factors from the intermembrane space.
Subcellular fractionation and Western immunoblotting
To identify changes in the subcellular localization of proteins, enriched mitochondrial and nuclear fractions were obtained using differential centrifugation. Briefly, cells were rinsed in PBS and then triturated from the dish and centrifuged. The pellets were resuspended in extraction buffer A (300 mM sucrose, 1 mM EDTA, 20 mM morpholinopropanesulfate) and protease inhibitors (Roche Products, Indianapolis, IN). After 30 min on ice, cells were lysed with 30 strokes of a glass Dounce homogenizer. The nuclei and any unbroken cells were then centrifuged at 100 ϫ g for 10 min at 4°C. The supernatant was centrifuged at 16,000 ϫ g for 20 min at 4°C to obtain an enriched mitochondrial heavy membrane fraction. Crude nuclear fractions and unbroken cells were meanwhile resuspended in lysis buffer B, which lyses outer cell but not nuclear membranes. This is the same buffer we used to lyse cells for nuclear counting (Rukenstein et al., 1991) . The nuclei were then washed three times by centrifugation and resuspension in PBS. The enriched mitochondrial and nuclear pellets were then lysed in buffer C (25 mM HEPES, pH 7.4, 5 mM EDTA, 1 mM EGTA, 5 mM MgCl 2 , and protease inhibitors) containing 1% Triton X-100 and submitted to Western immunoblotting. Protein concentrations were measured using the Bradford reagent (Bio-Rad, Hercules, CA). Equal volumes of 2 ϫ sample buffer were added to the lysates. The samples were then boiled for 10 min and subsequently resolved by electrophoresis on SDS-PAGE, transferred to nitrocellulose membranes, blocked in 5% nonfat milk in PBS, and incubated overnight at 4°C in 3% bovine serum albumin in PBS with various primary antibodies: mouse anti-AIF (1:500; Santa Cruz Biotechnology), mouse anti-cytochrome c (1:1000; PharMingen, San Diego, CA), mouse anti-subunit IV of COX (1:2500; Molecular Probes), used as a mitochondrial marker, and mouse anti-retinoblastoma protein (pRb) (1:1000; PharMingen), used as a nuclear marker. The blots were then washed in PBS with 0.2% Tween 20, incubated for 1 hr at RT with goat anti-mouse IgG antibody (Pierce, Rockford IL) at 1:10,000 in 5% milk in PBS, washed again, and then processed with the Pierce supersignal substrate system, according to the instructions of the manufacturer.
Transfection of cortical neurons
Cortical neurons were transfected with a vector [pCMS-enhanced green fluorescent protein (EGFP); Clontech, Cambridge, UK] encoding for EGFP alone or in addition to EGFP for human Superoxide dismutase 1 (SOD1) using a modified Lipofectamine 2000 reagent protocol (Life Sciences, Hialeah, FL). The correlation between expression of EGFP and SOD was ϳ90% as evaluated by immunocytochemistry using an anti-SOD antibody (Sigma). Neurons were then treated as above, and survival was assessed by counting the number of green fluorescent neurons in a defined area of the well at the time of treatment and after 20 hr. ROS generation in green fluorescing neurons was assessed in parallel by DHE staining as above.
Electron microscopy
Cultures were treated as above and then fixed for 1 hr at 4°C in Sorensen's buffer (0.1 M phosphate buffer; 1:4 monobasic:dibasic) containing 2.5% glutaraldehyde. Cells were then scraped off and centrifuged at 3000 ϫ g for 5 min. The pellet was maintained in Sorensen's buffer without glutaraldehyde and then processed for electron microscopy (EM) using standard methods (Tennyson et al., 1993; Stefanis et al., 2001 ).
Measurement of ATP levels
Neurons plated in 35 mm dishes or in 12-well dishes were rinsed from the dish in a small volume of PBS. A 50 l aliquot was submitted to the ATP luminometric assay kit (Roche Products) following the instructions of the manufacturer. The remaining neurons were lysed, and the intact nuclei were counted in a blinded manner as described above. ATP levels were then normalized to cell numbers. Measurements were performed in triplicate and are reported as mean Ϯ SEM. To measure specifically the ATP cellular content that was not derived from the mitochondria, some neurons were pretreated for 15 min with the mitochondrial ATP synthase inhibitor oligomycin, which blocks ATP production through the respiratory chain (2 g/ml; Sigma).
Results
The autophagic-lysosomal pathway is activated in caspase-independent cell death, but its inhibition does not offer protection We and others have shown that the DNA damaging agent camptothecin leads to caspase-dependent apoptosis of rodent embryonic cortical neurons (Morris and Geller, 1996; Park et al., 1998; Xiang et al., 1998; Stefanis et al., 1999; Keramaris et al., 2000; Morris et al., 2001; . Pharmacological or molecular inhibition of caspases prevents apoptosis in this model but leads to a delayed death lacking some of the classical features of apoptosis, such as chromatin fragmentation or terminal deoxynucleotidyl transferase-mediated biotinylated UTP nick end labeling staining (Stefanis et al., 1999; Keramaris et al., 2000) . It has been postulated that mitochondrial alterations might play a key role in this delayed cell death (Stefanis et al., 1999; Keramaris et al., 2000; Xue et al., 2001; Chang and Johnson, 2002; Cregan et al., 2002) . In certain situations, mitochondrial dysfunction may lead to activation of autophagy (Lemasters et al., 1998; Elmore et al., 2001) . Autophagy is the process through which double membrane structures, thought to emanate from the endoplasmic reticulum, engulf intracellular organelles or parts of the cytoplasm. Such autophagic bodies are converted to autophagolysosomes and eventually mature lysosomes through fusion with lysosomes. The contents of autophagic bodies are thus eventually digested by lysosomal acidic enzymes (Larsen and Sulzer, 2002) .
To study whether the process of autophagy is activated in caspase-independent death in our model, we treated E18 rat cortical neurons with camptothecin and the general caspase inhibitor BAF for 20 hr and submitted the cultures to ultrastructural analysis, which is the gold standard for the identification of this process (Xue et al., 1999; Larsen and Sulzer, 2002) . At this time point, as we have shown previously, caspase-independent cell death occurs in this model (Stefanis et al., 1999) . In parallel, we examined cultures treated with camptothecin alone for 10 hr. As expected, clear features of apoptosis were observed in this early caspase-dependent death ( Fig. 1 B) . In contrast, although some chromatin condensation and margination was observed at late stages in the delayed caspase-independent cell death ( Fig. 1C,D) , nuclear features like the intense chromatin clumping and fragmentation of the nucleus as seen in classical apoptotic cell death were not found. Many cells in these cultures treated with the combination of camptothecin and BAF showed clear features of autophagy (Fig. 1C,D) . Counts of autophagic bodies defined as intracytoplasmic double-membrane structures engulfing cellular material were performed blindly in random EM images and confirmed an activation of autophagy in delayed death (Fig. 2 A) .
Autophagy has been invoked as a mechanism through which neonatal rat sympathetic neurons undergo caspase-independent cell death (Xue et al., 1999) . We therefore tested whether the autophagy inhibitor 3 methyladenine (3-MA) (Seglen and Gordon, 1982; Xue et al., 1999; Petiot et al., 2000) would attenuate caspase-independent death in our model. We treated the cultures with camptothecin and BAF and added 3-MA 8 hr later. This was done because 3-MA partially inhibited caspase-dependent cell death (data not shown), and we did not wish this effect to interfere with the later caspase-independent death. As shown in Figures 1, E and F, and 2 B, 3-MA partially inhibited the activation of autophagy in neurons treated with camptothecin and BAF. However, caspase-independent death was not attenuated (Fig. 2C) .
To assess whether the induction of autophagy was associated with a general activation of the lysosomal pathway, we used the dye Lysotracker Red. We observed intense, globular Lysotracker Red labeling in delayed death. This was attenuated in the presence of 3-MA (data not shown), suggesting that the increased autophagy led to a general activation of the lysosomal pathway.
We also used an alternative strategy to inhibit the pathway of lysosomal activation by applying the pharmacological agent bafilomycin, which is a specific inhibitor of the vacuolar ATPase pump that is responsible for the acidification of lysosomes (Bowman et al., 1988) . Bafilomycin blocks the fusion of autophagic bodies with lysosomes and would thus be expected to lead to an increase of ultrastructural evidence of autophagy but a functional inhibition of the lysosomal pathway (van Deurs et al., 1996; Yamamoto et al., 1998) . Bafilomycin is usually used at concentrations of 50 -100 nM. However, we found that at these concentrations it was markedly toxic to our cultures. We therefore applied this agent at a concentration of 2.5 nM, which still completely inhibited the acidification of lysosomes, as judged by complete loss of specific Lysotracker Red labeling. Bafilomycin led to an increase in ultrastructural features of autophagy and was not toxic over the period of 24 hr (data not shown). Despite this, it also failed to protect against caspase-independent death (Fig. 2C) .
Reactive oxygen species are generated in caspase-independent neuronal death, and the antioxidant Tempol offers protection against neuronal death Mitochondrial dysfunction has been described to lead to the generation of ROS, which could be a contributing factor to cell death (Zamzami et al., 1995; Green and Reed, 1998) . Therefore, we first investigated whether ROS are generated in our model of caspaseindependent cell death. To assess ROS generation, we used the fluorescent dyes DHE and DCF. In the case of DHE labeling, we concurrently labeled the cultures with the viability dye calcein AM to ensure that the neurons counted as showing ROS generation were still viable. We found that a significant percentage of neurons treated with the combination of camptothecin and BAF accumulated ROS over time (Fig. 3 A, C) . The time course of ROS accumulation as shown in Figure 3C in parallel with the time course of neuronal death showed that this was a relatively late event and correlated closely with the onset of death in the cultures. Similar results were obtained qualitatively with DCF labeling (Fig. 3B) . The neurons labeled with DCF still have an intact outer membrane as shown by exclusion of ethidium homodimer but, on phase, show signs of advanced degeneration.
We then investigated whether antioxidant pharmacological agents would have a protective effect in this caspase-independent death. A range of common antioxidants, including vitamin E, Trolox, NAC, GSH-MEE, Tiron, MnTBAP, or MnTMPyP, used at standard concentrations (see Materials and Methods) had no effect on survival. Representative data from an experiment with vitamin E are shown in Figure 4 A. In parallel experiments, we examined whether such antioxidants prevented the generation of ROS. Surprisingly, we found that they did not, even when high concentrations had been used (see range of concentrations used in Materials and Methods) or when they had been re-added after 10 hr of treatment (see Fig. 4 A for representative experiment with vitamin E). These data raised the possibility that the antioxidant ( E, F ) . B, A classical apoptotic cell with condensed and fragmented chromatin within the nucleus (arrow) and a shrunken cell body can be appreciated. We found no such cells after the combined application of camptothecin and BAF. Nuclear alterations in this delayed death do not progress beyond some degree of chromatin condensation and margination as seen in D. Instead, many cells showed signs of autophagy (C,D). The arrows point to autophagolysosomes. Such marked autophagic features were not seen in control or camptothecin alone-treated cultures. E, F, Features of autophagy were decreased by 3-MA ( E, F ), even in clearly degenerating neurons ( F). Although some autophagolysosomes appear to engulf mitochondria (C, top arrow), normal looking mitochondria can still be found in the cytoplasm (C, arrowheads). Scale bar, 1 m. Figure 2 . A, Increase in autophagic bodies in caspase-independent neuronal death. Random electron microscopic images of cortical neurons treated with no additive (ctrl) or with camptothecin plus BAF (camϩBAF) for 20 hr were analyzed. Autophagic bodies defined as intracytoplasmic double-membrane bound structures engulfing cellular material were counted in a blinded manner. In parallel, mitochondria were counted in both conditions. Numbers are reported as the mean Ϯ SEM (n ϭ 20; *p Ͻ 0.01; Student's t test) . B, Addition of 3-MA inhibits the activation of autophagy. The addition of 3-MA (10 mM; added with an 8 hr delay) to cortical neurons treated with camptothecin and BAF reduces the amount of autophagic bodies, counted as in A in a blinded manner in random electron microscopic images. Numbers are reported as the mean Ϯ SEM (n ϭ 10). Although, as in A, there was an increase in the number of autophagic bodies in camϩBAF-treated cultures ( p ϭ 0.027), cultures treated with the addition of 3-MA showed no such increase compared with controls ( p ϭ 0.21), implying that autophagy was not activated in the presence of 3-MA. C, Inhibitors of autophagy or of the vacuolar proton pump do not protect against caspase-independent cell death. Cortical E18 neurons were treated with camptothecin plus BAF in the presence or absence of the autophagy inhibitor 3-MA (10 mM) or of the inhibitor of the vacuolar ATPase proton pump bafilomycin (2.5 nM). After 20 hr, the number of surviving neurons was assessed by counting the remaining intact nuclei. Survival is reported relative to untreated controls and is the mean Ϯ SEM (n ϭ 3). Addition of 3-MA (added 8 hr after treatment with camptothecin and BAF) or bafilomycin had no effect on caspase-independent death. This is representative of three independent experiments. treatments used may not be effective as antioxidants in our system. We thus tested these substances in another model of oxidative stress, in which neuronal death was induced by culturing the neurons for 48 hr in antioxidant-free medium (neurobasal medium plus antioxidant-free B-27 supplement). All of these agents were effective in preventing the generation of ROS and neuronal death in this model (see Fig. 4 B for representative experiment with vitamin E).
As an alternative approach to a pharmacological reduction of oxidative stress, we overexpressed the antioxidant protein human SOD1 in the cultures and again obtained no effect on either ROS generation or neuronal death (data not shown). Because the B-27 supplement routinely used in the cultures already contains antioxidants, we hypothesized that a reason for the lack of effect of antioxidants on caspase-independent ROS generation may be that there is already a saturating concentration of antioxidants in the medium. We therefore performed the same experiments in neurobasal medium plus antioxidant-free B-27 supplement with 2.5 g/ml of vitamin E, which was the minimum concentration that maintained viability of control cultures for several days. Even in these conditions, the addition of vitamin E (100 g/ml) or MnTBAP had no effect on ROS generation or survival of neurons exposed to camptothecin and BAF (data not shown).
We next cotreated our cultures with the substance Tempol, a cell permeable nitroxide that acts as a free radical scavenger and spin trap agent (Cuzzocrea et al., 2000; Thiemermann et al., 2001) . Because Tempol was effective in preventing caspasedependent cell death, it was added to the cultures after 10 hr of treatment with camptothecin and BAF. At this time point, the majority of the neurons treated with camptothecin alone had undergone cell death, and no additional protection could be achieved by the addition of Tempol (Fig. 5A) . However, caspaseindependent cell death was significantly abrogated by Tempol, even when added in a delayed manner (Fig. 5 A, B) . This result was obtained by counting both the intact nuclei of lysed neurons (Fig. 5A ) and calcein AM-positive neurons in the culture dishes (Fig. 5B) . The discrepancy in the absolute number of surviving neurons between these two methods is likely attributable to the fact that nuclear alterations occur before the disruption of the cellular membrane, and thus neurons with a damaged nucleus would still be counted as calcein AM positive. We next assessed the oxidative activity in neurons and found that Tempol reduced the generation of ROS, as indicated by DHE labeling (Fig. 5C ).
AIF and the mitochondrial permeability transition pore are not involved in caspase-independent neuronal death AIF is a mitochondrial death effector that is released from the intermembrane space after certain death stimuli. It then translocates to the nucleus, where it induces large-scale DNA fragmentation and chromatin condensation (Susin et al., 1999; Daugas et al., 2000) . Although some studies report that AIF is released after A, Cortical neurons were treated with camptothecin and BAF (camϩBAF) for 20 hr. Concomitant treatment with the antioxidant vitamin E (100 M), which was re-added after 12 hr, did not have an effect on survival, as assessed by nuclear counts, and also failed to protect against ROS generation (percentage of DHE-positive neurons relative to live neurons). In contrast, vitamin E was effective in preventing the ROS generation and death in neurons plated and cultured for 48 hr in antioxidant-free medium ( B). (5 mM) 10 hr after the onset of treatment had no effect on survival in neurons treated with camptothecin alone (nuclear counts after 14 hr) but significantly improved survival in neurons treated with camptothecin and BAF as assessed by nuclear counts after 20 hr. B, Counts of live (calcein AM-positive) neurons in a defined number of fields in each well confirmed the protective effect of Tempol. C, In parallel, ROS generation reported as the percentage of DHE-positive neurons relative to live neurons was assessed. All counts were conducted in a blinded manner. Numbers are reported as the mean Ϯ SEM (A, B, n ϭ 4; C, n ϭ 3; *p Ͻ 0.01; #p Ͻ 0.05; Student's t test).
cytochrome c in a caspase-dependent manner (Arnoult et al., 2002 (Arnoult et al., , 2003 Wang et al., 2002) , it has also been shown to translocate independently of caspase activation (Susin et al., 1999; Daugas et al., 2000; Cregan et al., 2002) . It thus seemed a possible candidate as a death effector in our caspase-independent cell death model. We first used immunostaining with an AIF antibody, concurrently with labeling with the mitochondrial marker Mitotracker Green and a nuclear dye. We found no evidence of translocation of AIF to the nucleus 20 hr after treatment with camptothecin and BAF (Fig. 6 A) . This result was confirmed through the use of another AIF antibody, a rabbit polyclonal antiserum generously provided by Drs. Kroemer and Susin (data not shown). In addition, Western immunoblotting of nuclear and mitochondrial fractions showed that, although cytochrome c release occurred from the mitochondria in caspase-independent death, there was no loss of AIF from the mitochondria, and there was no accumulation of AIF in the nuclear fraction (Fig. 6 B) .
Opening of the mitochondrial permeability transition pore (PTP) was recently proposed as a mechanism accounting for caspase-independent death of sympathetic neurons (Chang and Johnson, 2002) . We therefore investigated whether inhibitors of the PTP would affect loss of MTP or survival in caspase- Figure 6 . There is no obvious translocation of AIF from the mitochondria to the nucleus in caspase-independent cell death. A, After treatment with no additives (control) or with camptothecin and BAF (camϩBAF) for 20 hr, the neurons were stained with Mitotracker Green to label mitochondria. After fixation, neurons were immunostained with an anti-AIF monoclonal antibody and counterstained with the nuclear dye TOTO. Confocal imaging shows colocalization of AIF with Mitotracker Green in controls as well as treated cells. There was no nuclear AIF translocation observed, even in frankly degenerating cells. The reduction of Mitotracker Green in treated cells is likely attributable to some loss of mitochondria (Fig. 2 A) . B, Cultured E18 neurons were treated with camptothecin and BAF (camϩBAF) for 20 hr, and subcellular fractions were obtained by differential centrifugation. Proteins from the enriched mitochondrial fraction (mito; 40 g) and the enriched nuclear fraction (nuc; 20 l) were then separated by SDS-PAGE, blotted to nitrocellulose membranes, and probed with the indicated antibodies. 
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There is clear loss of cytochrome c but not of AIF in the mitochondrial fraction. There is no accumulation of AIF in the nuclear fraction during the time tested. pRb and COX are used as markers of the nuclear and mitochondrial fractions, respectively, and as controls for protein loading.
independent death. We found no effect of two different PTP inhibitors, cyclosporin A or bongkrekic acid, on either parameter (Fig. 7A-C) .
Mitochondrial ATP levels are diminished specifically in caspase-independent neuronal death One consequence of the loss of cytochrome c can be the disruption of the mitochondrial respiratory chain, in particular at the level of complexes III and IV and, consequently, of the energy metabolism of the cell. Although a drop in ATP production has been observed in apoptotic death, it seems to occur fairly late and is not generally considered a mechanism for induction of apoptosis (Bossy-Wetzel et al., 1998; Green and Reed, 1998) . Presumably, caspase activation and execution of apoptotic cell death occur very shortly after cytochrome c release, before a drop in energy levels leads to cellular dysfunction and death (Green and Kroemer, 1998) . However, in a setting where caspases are inhibited, cells may remain alive with dysfunctional mitochondria for more prolonged periods of time. As we have shown previously, Ͼ60% of neurons treated with camptothecin and BAF show mitochondrial cytochrome c release, and Ͼ30% lose mitochondrial transmembrane potential after only 10 hr of treatment. At this time point, little if any cell death has occurred (Stefanis et al., 1999) .
We therefore analyzed the cellular energy levels at a similar time point in neurons treated with camptothecin and BAF. ATP levels were measured by a luminometric assay and were normalized to cell number. After 12 hr of treatment, cellular ATP levels dropped by Ͼ40% compared with controls (Fig. 8 A) . Almost 70% of cellular ATP levels in control cultures was inhibited by oligomycin, and was therefore of mitochondrial origin (Fig. 8 A) . Nonmitochondrial ATP levels were similar in controls and in neurons treated with camptothecin and BAF, indicating that the ATP reduction in the treated neurons occurs in the mitochondria-generated ATP (Fig. 8 A) . To ensure that energy depletion occurs specifically in caspase-independent death, we also measured ATP levels in neurons treated with camptothecin alone. After 6 hr of treatment, at a time point when caspases are activated and survival levels are similar to those observed after 12 hr of combined camptothecin and BAF treatment, ATP levels were not diminished compared with controls (Fig. 8 B) .
Manipulation of cellular ATP levels alters caspase-independent death
Having shown that there was a relative depletion of cellular ATP levels in caspase-independent death, we investigated whether providing neurons with an alternative source of ATP, namely glycolysis, would have an affect on the cellular energy state and cell death. Because the neurobasal medium that we used in previous experiments contains high amounts of glucose, we performed experiments to address this issue in a glucose-free medium supplemented with pyruvate. Neurons survive in this medium for several days. The reduction of mitochondrial ATP production observed in caspase-independent death was reproduced under these glucose-free culture conditions. The addition of glucose to the medium simultaneously with camptothecin and BAF led to a significant increase of cellular ATP levels 12 hr later. As shown by inhibition of mitochondrial ATP production by Figure 8 . A specific decrease of mitochondria-derived ATP occurs in caspase-independent death. A, E18 cortical neurons were treated with no additives (ctrl) or with camptothecin and BAF (camϩBAF) for 12 hr. Cells were then harvested for ATP measurements and parallel assessment of survival by nuclear counts. ATP levels were measured with a luminometric assay kit (Roche Products), normalized to cell numbers, and represented as the mean Ϯ SEM (n ϭ 3). To assess ATP that was not derived from the mitochondria, neurons were treated with oligomycin (2 g/ml) for 15 min before ATP measurements. Although the nonmitochondrial ATP (white bars) did not change, there was a significant decrease of total ATP content in cultures treated with camϩBAF compared with controls (gray bars; **p Ͻ 0.001; Student's t test). B, E18 cortical neurons were treated for 6 hr with no additives (ctrl) or with 10 M cam, and total ATP content was assessed as above. There was no difference in ATP content between the two conditions. These are representative of three independent experiments, all performed in a blinded manner. Figure 9 . Modulation of nonmitochondrial source of ATP leads to a specific increase of survival in caspase-independent death. A, E18 cortical neurons were plated and cultured in glucose-free RPMI medium containing 5 mM pyruvate and the supplement B-27. The cells were exposed to no additives (ctrl), 4 mg/ml D-glucose (ctrlϩglu), or 10 M camptothecin and 100 M BAF (camϩBAF) or glucose, camptothecin, and BAF (camϩBAFϩglu). Measurements of ATP levels were obtained with (white bars) or without (gray bars) a 15 min pretreatment with oligomycin. As in Figure 8 A, there was a decrease of total ATP content with the cam and BAF treatment in the glucose-free medium after 12 hr of treatment. The addition of glucose significantly augmented total ATP content in cultures treated with cam and BAF (*p Ͻ 0.05) by increasing the nonmitochondrial ATP (#p Ͻ 0.01). However, the increase in total ATP by the addition of glucose was not sustained over time, as shown by the measurements at 20 hr. B, E18 cortical neurons were plated and cultured in glucose-free medium. They were then treated with no additives (ctrl), camptothecin for 12 hr (cam 12 hr), or cam and BAF for 20 hr in the presence or absence of 4 mg/ml D-glucose. The presence of glucose (white bars) offered no survival advantage to control cells or to those exposed to camptothecin but significantly attenuated caspase-independent cell death (*p Ͻ 0.05). C, Counts of live (calcein AM-positive) neurons in a defined number of fields in each well confirmed the protective effect of glucose in caspaseindependent cell death (*p Ͻ 0.01). D, Neurons were cultured in glucose-free medium as above and were then treated for 16 hr with no additives (ctl), glucose (ctlϩglu), camptothecin and BAF (cϩB), or camptothecin and BAF plus glucose (cϩBϩglu). Proteins from enriched mitochondrial fractions were then obtained by differential centrifugation of the cell lysates and analyzed by immunoblotting with indicated antibodies. The addition of glucose had no effect on mitochondrial cytochrome c content in either control conditions or neurons treated with camptothecin and BAF. COX is used as a marker for protein loading. This is representative of two independent experiments and shows similar results as two additional experiments in which lysates were collected after 12 hr of treatment.
oligomycin, this increase in ATP levels was attributable to nonmitochondrial sources (Fig. 9A) . However, this increase in ATP levels was not sustained over time: 20 hr after treatment, ATP content dropped and reached the levels observed in neurons not supplemented with glucose after 12 hr of treatment with camptothecin and BAF. This drop in ATP production was primarily attributable to an additional loss of mitochondrial ATP.
We then evaluated the effects of this increase of cellular ATP levels on caspase-independent death. After 20 hr of treatment, we found an ϳ80% increase in survival of neurons supplemented with glucose: 27 Ϯ 6.4% of neurons survived in the glucose-free condition, whereas 49 Ϯ 7% survived in the glucose-containing medium (Fig. 9B ). This survival effect was specific because apoptotic cell death induced by camptothecin alone was not affected (Fig. 9B) . The beneficial effect of glucose on survival in caspaseindependent death was confirmed by counts of calcein AMpositive neurons in the culture dishes (Fig. 9C) . Again, as in the case of antioxidant treatment (Fig. 5B) , the absolute numbers of surviving neurons were found to be higher with this method.
Because it has been reported that high concentrations of glucose might lead to alterations in the levels of bcl-2 protein family members and thus could prevent cytochrome c release (Schaffer et al., 2000; Pampfer et al., 2001; Sakuma et al., 2002) , we investigated whether the addition of glucose would affect loss of mitochondrial cytochrome c in our model. Immunoblots of cytochrome c in crude mitochondrial fractions of cell lysates were performed at two different time points after treatment (two Western blots at 12 or 16 hr each) and showed no effect on mitochondrial cytochrome c release with glucose supplementation (Fig. 9D) .
Increasing intracellular ATP and reducing oxidative stress leads to an additive increase in neuronal survival Because both increasing intracellular ATP by supplementation with glucose and reducing free-radical generation by the addition of the antioxidant Tempol had shown beneficial effects on neuronal survival, we investigated whether combining the strategies could lead to an additive effect. In two different experiments, neurons were treated for 20 hr as above with and without glucose and with and without the addition of Tempol. Although supplementation of glucose alone increased survival by ϳ90% and the addition of Tempol alone increased survival by ϳ70%, the combination of both treatments led to a 2.6-fold increase in survival. However, many neurons still died in these experiments, even with the combined treatment of Tempol and glucose (data not shown).
Discussion
Caspase-independent death has recently been recognized as a potential limiting factor in the usefulness of caspase-directed therapies for neurological diseases (for review, see . We (Stefanis et al., 1999; Keramaris et al., 2000) and others (Xue et al., 1999; Chang and Johnson, 2002; Cregan et al., 2002) have been studying the mechanisms through which such neuronal cell death occurs, and have suggested that alterations at the level of the mitochondria, apart from their better established pro-apoptotic effects, may also lead to caspaseindependent death. Identification of such mechanisms may lead to combined treatment approaches that are more effective than caspase inhibition alone and may offer insights into the way neurons degenerate in the absence of apparent caspase activation in a number of neurodegenerative conditions (Stefanis et al., 1999; ).
Mitochondrial energy depletion is a mechanism of caspaseindependent neuronal death A major finding of the current work is that a specific decrease of mitochondrially generated ATP occurs in cultured rat cortical neurons treated with the combination of camptothecin and a general caspase inhibitor. More importantly, manipulation of cellular ATP levels leads to enhanced survival in this model of caspase-independent neuronal death. Thus, caspaseindependent neuronal death is, at least in part, attributable to energy depletion. Such mitochondrial energy depletion and subsequent death may occur secondary to caspase-independent cytochrome c release (Stefanis et al., 1999) and the ensuing loss of function of complexes III and IV of the respiratory chain. Consistent with this, caspase-independent redistribution of cytochrome c leads to mitochondrial respiratory dysfunction in Fas-stimulated hepatocytes (Mootha et al., 2001) , and treatment of cortical neurons with the complex III inhibitor antimycin A leads to caspaseindependent death (Stefanis et al., 1999) .
Another event that occurs in caspase-independent neuronal death is the loss of MTP. This, unlike cytochrome c translocation, occurs in a slightly delayed manner in the presence of caspase inhibitors, implying that caspases may be partially involved in MTP loss, perhaps in a positive feedback loop (Stefanis et al., 1999) . A caveat is that the cationic dyes that we used may also be sensitive to changes in plasma membrane potential, the loss of which was recently demonstrated to be caspase-dependent (Dussmann et al., 2003) . Consistent with the idea that caspases partially affect MTP, caspase-3 inhibits the respiratory chain and leads to loss of MTP (Ricci et al., 2003) . MTP loss does eventually occur in our model and is nearly complete by 20 hr (Stefanis et al., 1999) (Fig. 7 A, B) . The inability to maintain a proton gradient across the mitochondrial membrane may be the result of impaired electron transport through the dysfunctional respiratory chain and may contribute to mitochondrial energy failure.
To counteract the decline in cellular ATP content, we used glucose, which would be expected to lead to an increase of ATP production through glycolysis and not through the malfunctioning mitochondria. Such an increase in nonmitochondrial ATP was indeed observed and led to enhanced survival specifically in caspase-independent death. It should be noted however that this strategy was only partially and transiently effective in restoring cellular ATP levels. It remains to be seen whether other strategies aimed at restoring the energy state of the neurons may be more effective in preventing neuronal death.
A free-radical scavenger protects against caspase-independent death ROS may kill in a caspase-independent manner and have been suggested as ancestral mediators of programmed cell death in organisms that lack caspases (for review, see Fleury et al., 2002) . Because mitochondrial alterations and, in particular, loss of cytochrome c have been shown to induce ROS generation (Cai and Jones, 1998) , we investigated the role of ROS in our model. We found increased generation of ROS in caspase-independent death; however, this was a relatively late event, occurring close to the time of cell death. The substance Tempol, a nitroxide acting as free-radical scavenger and spin trap agent (Cuzzocrea et al., 2000; Thiemermann et al., 2001) , diminished oxidative stress and improved survival. However, many common antioxidants, as well as the overexpression of SOD, had no effect on neuronal death or ROS generation, although they were effective in another model of oxidative stress. Why these antioxidant treatments were not ef-fective is yet unclear. It could be that they did not penetrate the cell well or that they were not able to withstand the high levels of oxidative stress present within the cell, whereas Tempol as a free radical scavenger had a better effect. Alternatively, superoxide may react with NO to form peroxynitrite at a faster rate than it is processed to H 2 O 2 by SOD, especially under conditions of enhanced NO formation (Dyckens 1997; Radi et al., 2002) . In addition, peroxynitrite reacts with the Mn center of SOD, leading to its inactivation and a subsequent decrease in O 2 dismutation, thus initiating a positive feedback cycle (Radi et al., 2002) . Potentially, the more "classic" antioxidants and SOD treatment are not efficient enough to disrupt this reaction. Tempol can efficiently scavenge peroxynitrite and other nitrogen-derived free radicals (Thiemermann et al., 2001; Bonini et al., 2002) and thus may lead to interruption of this feedback loop. Alternatively, NO produced from the neurons or NO products like nitrites contained in the cell culture medium could react with O 2 and form radicals that become fatal in neurons already compromised in their antioxidant defenses.
Autophagy and lysosomal activity are increased but are not instrumental in caspase-independent neuronal cell death Autophagy is not only a normal response of hepatocytes to nutrient deprivation but also a specific type of developmental neuronal cell death (Mortimore and Poso, 1986; Clarke, 1990 ). Autophagy may thus represent an alternative form of programmed cell death (Clarke, 1990; Xue et al., 1999; Saeki et al., 2000) . We show here that autophagy is activated in caspase-independent death of cultured E18 cortical neurons and that it leads to a general activation of the lysosomal pathway. However, autophagy is not instrumental to caspase-independent neuronal death in our model, because inhibitors of autophagy or of the vacuolar ATPase were not protective. This is in contrast to the findings of Xue et al. (1999) , who found that 3-MA protected against rat sympathetic neuron caspase-independent death. In the same model, mitochondria were selectively eliminated by an autophagic process (Xue et al., 2001) . Although some mitochondria were sequestered in autophagic vacuoles and numbers of mitochondria were found to be diminished (Fig. 2 A) , complete elimination of mitochondria does not occur in our model. After 20 hr of treatment with camptothecin and BAF, intact mitochondrial profiles were still found (Fig. 1C) , and COX IV protein levels were preserved (Fig. 6 B) . The difference in the fate of mitochondria between these two models might account for, in part, the importance of autophagy in eliciting neuronal death. It is possible that in our model, the temporal relationship between loss of mitochondrial function and autophagic sequestration is different from the model of Xue et al. (1999 Xue et al. ( , 2001 ) and, thus, neuronal death might occur through energy depletion, free radical generation, and potentially other mechanisms before cell death resulting from autophagy occurs.
AIF translocation and PTP opening are not involved in caspase-independent neuronal death
In contrast to a recent study using a very similar model of caspase-independent neuronal death in which camptothecin was administered to mouse cortical neurons lacking apoptotic protease activating factor-1 (Apaf-1) (Cregan et al., 2002) , we found no evidence for translocation of the mitochondrial death mediator AIF from the mitochondria to the nucleus. There are several differences between our study and that of Cregan et al. (2002) that could account for this discrepancy: species differences, different dissection and culture protocols, and a different temporal evolution of caspase-independent death. Alternatively, compensatory pathways, such as upregulation of an AIF death pathway, may be activated in Apaf-1 knock-out mice. Consistent with this idea, the caspase 9/3 pathway shows compensatory activation in caspase 2 knock-out mice (Troy et al., 2001) .
Our findings of the lack of PTP involvement in our model contrast with another recent study in which administration of 10 M of the PTP inhibitor cyclosporin A had selective survival effects on caspase-independent but not caspase-dependent death of NGF-deprived rat sympathetic neurons (Chang and Johnson, 2002) . The dose of cyclosporin A used was 10-fold higher than in our study. We were unable to use this agent at such high concentrations because of its toxicity (data not shown); however, in a previous study, cyclosporin A exerted effects on mitochondrial alterations and neuronal death at concentrations as low as 200 nM (Khaspekov et al., 1999) . Furthermore, another PTP inhibitor, bongkrekic acid, used at concentrations as high as 50 M also failed to prevent loss of transmembrane potential and neuronal death. We conclude that the loss of MTP occurs through another mechanism and that opening of the PTP is not required for caspase-independent death in our model.
In conclusion, our present study provides evidence that autophagy is the morphological form of caspase-independent neuronal death. This death occurs, at least in part, because of energy depletion and generation of free radicals. The survivalpromoting effect of increasing cellular ATP levels and reducing free radicals is additive, suggesting different mechanisms of action. So far, in caspase-independent neuronal death, more attention has been paid to specific molecules that may be released by the mitochondria in a caspase-independent manner (Chang and Johnson, 2002; Cregan et al., 2002) . We cannot exclude that other potential mediators might also be a factor in our model of caspase-independent death, especially because combined treatment targeted against both energy depletion and free radical generation did not lead to complete survival. However, our findings argue that the general energy and redox state of the neurons play a critical role. Antioxidant treatment in combination with an optimized delivery of alternative sources of energy to neurons that are temporarily saved by caspase inhibition would appear to be a valuable therapeutic strategy, especially in situations in which the death stimulus continues to be present.
